Insider Transactions in Q3 2022 at Edgewise Therapeutics, Inc. (EWTX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Sep 16 2022	Peter A. Thompson	BUY Open market or private purchase	Indirect	484,496 +3.35%	$4,844,960 $10.32 P/Share
Sep 16 2022	Orbimed Advisors LLC Director	BUY Open market or private purchase	Indirect	484,496 +3.35%	$4,844,960 $10.32 P/Share
Sep 14 2022	Novo Holdings > 10% Shareholder	BUY Open market or private purchase	Direct	484,496 +7.39%	$4,844,960 $10.32 P/Share
Sep 06 2022	John R Moore General Counsel	SELL Open market or private sale	Direct	4,730 -37.36%	$47,300 $10.91 P/Share
Sep 06 2022	John R Moore General Counsel	BUY Exercise of conversion of derivative security	Direct	4,730 +37.96%	$4,730 $1.93 P/Share
Aug 03 2022	John R Moore General Counsel	SELL Open market or private sale	Direct	9,232 -75.47%	$83,088 $9.31 P/Share
Aug 03 2022	John R Moore General Counsel	BUY Exercise of conversion of derivative security	Direct	9,232 +32.43%	$9,232 $1.32 P/Share
Jul 06 2022	John R Moore General Counsel	SELL Open market or private sale	Direct	1,046 -25.85%	$8,368 $8.54 P/Share
Jul 06 2022	John R Moore General Counsel	BUY Exercise of conversion of derivative security	Direct	1,046 +20.54%	$1,046 $1.93 P/Share
Jul 05 2022	John R Moore General Counsel	SELL Open market or private sale	Direct	8,186 -73.18%	$65,488 $8.35 P/Share
Jul 05 2022	John R Moore General Counsel	BUY Exercise of conversion of derivative security	Direct	8,186 +32.11%	$8,186 $1.32 P/Share

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Value

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

Operation

Value

Type

Receive news related to Edgewise Therapeutics, Inc.